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Abstract plO/NTFZ is a cytosolic factor which is required for 
the translocation step in nuclear protein import in an in vitro 
assay with digitonht-permeabilized cells. To study the functional 
roles of plO/NTFZ on protein transport between the nucleus and 
cytoplasm in living cells, recombinant plO/NTFZ was micro- 
injected into cultured mammalian cells. Cytoplasmically injected 
plO/NTFZ strongly inhibited the nuclear import of co-injected 
NLS-containing substrates in a dose-dependent manner but had 
no effect on the diffusive import of small non-nuclear proteins. 
Moreover, when injected into the cell nucleus, plO/NTFZ 
inhibited the nuclear export of NES-contalnhtg substrates. The 
results suggest that the nuclear import factor plOINTF2 may 
also be involved in the nuclear export of proteins and that the 
protein transport efficiency between the nucleus and cytoplasm 
may be regulated by the intracellular level of plO/NTFZ. 
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1. Introduction 
Nuclear localization signal (NLS)-mediated protein import 
into the nucleus can be divided into two distinct steps, (a) 
binding to the nuclear pore complex (NPC) and (b) transloca- 
tion to the interior of the nucleus [l-3]. Studies involving both 
in vivo and in vitro nuclear import assay systems have identi- 
fied several factors which are required for these steps [4]. 
Hsc70 (a 70 kDa heat shock cognate protein) constitutes 
one of these factors [5-71. During the initial stage of nuclear 
import, an NLS-containing substrate forms a stable complex 
(referred to as the nuclear pore-targeting complex, PTAC) 
with 58 kDa and 97 kDa components to target the nuclear 
pore [8,9]. The 58 kDa component of PTAC (PTACSS) has 
been shown to bind directly to the NLS and has been desig- 
nated the NLS receptorlimportin-alkaryopherin-a [lO-141. 
The 97 kDa component of PTAC (PTAC97) is required for 
interaction of the substrate-58 kDa component complex with 
the NPC and is referred to as p97/importin-P/karyopherin-P 
[9,15-l 81. Using digitonin-permeabilized cells, a small GTPase 
Ran/TC4 [19,20] and its interacting protein, ~10 [21], have 
also been identified as cytosolic factors which are required 
for the translocation step in nuclear import. The Ran GTPase 
cycle has been shown to regulate nuclear import in living cells 
[22]. p10 has been shown to interact with nuclear pore protein 
p62 and is referred to as NTF2 [23]. The mechanism by which 
plO/NTF2 acts on nuclear protein transport in living cells, 
however, remains unknown. 
Recently, the signal required for the nuclear export (nuclear 
export signal, NES) of certain proteins has been identified 
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[24-281. The NES-mediated nuclear export has been shown 
to be temperature- and ATP-dependent. Little, however, is 
known about the machinery involved in this export. 
In this paper, we wish to report on a study involving the 
microinjection of recombinant plO/NTF2 protein into cul- 
tured mammalian cells in an attempt to better understand 
the functional roles of plO/NTF2 on nuclear transport in liv- 
ing cells. The results suggest that plO/NTF2 may regulate not 
only nuclear import, but also nuclear export. 
2. Materials and methods 
2.1. Cell cultures _ 
Human embryonic lung (HEL) and Madin-Darby bovine kidney 
(MDBK) cells were cultured in 5% CO? at 37°C in Dulbecco’s mod- 
ified Eagle’s minimum essential (DME) medium (Gibco BRL) supple- 
mented with 10% bovine calf serum (Hyclone). 
2.2. Cloning and pur$cation of recombinant human plOINTF2 
Human plO/NTFZ/pplS gene 1291 was amplified from HeLa cell 
cDNA by the polymerase chain-reaction (PCR) using the primers 
5’-AGCTAGCATATGGGAGACAAGCCAATTTGGGAG-3’ and 
5’-AGCTAGAGATCTTCAGCCAAAGTTGTGCAGGGC-3’. The 
PCR product was digested with NdeI and BnflI and inserted into 
NdeI-BarnHI-digestedpET3a vector (Novagen). The plasmid was in- 
troduced into E. coli strain BL21(DE3). The exnression of DIO/NTFZ 
proteins was induced by the addition of 1.0 mM isopropy&-thio- 
galactopyranoside to exponentially growing cultures (ODsas = 0.3) in 
50 ml of LB medium containing ampicillin. The cultures were incu- 
bated for 6 h at 37”C, after which the bacteria were harvested by 
centrifugation and frozen at -20°C. The cell pellet was resuspended 
in lysis buffer (50 mM Tris-HCl, pH 8.0, 1.0 mM ethylenediamine 
tetraacetic acid, 0.5 mM dithiothreitol (DTT) and 0.1 mM @-amidi- 
nophenyl)methanesulfonyl fluoride). After two freeze-thaw cycles, the 
cells were disrupted by sonication. After centrifugation for 30 min at 
15 OOOXg, the supernatant was subjected to chromatography on a 
Hitrap Q column (1 ml) in FPLC system (Pharmacia) at a flow rate 
of 0.2 ml/min using a linear gradient of O-500 mM NaCl in 20 mM 
HEPES-NaOH buffer (pH 7.3). plO/NTFZ eluted between 150 and 
200 mM NaCI. Peak fractions containing plO/NTF2 were pooled, 
the pooled fractions sieved on a Superose 12 FPLC column (HR30/ 
10, Pharmacia) and equilibrated with 20 mM HEPES-NaOH, pH 7.3 
and 100 mM KOAc. Peak fractions containing plO/NTF2 were 
pooled and concentrated in a Millipore centrifugal concentrator (Ul- 
tra Free, C3), and 10 ~1 aliquots were frozen in liquid nitrogen and 
stored at -80°C. 
2.3. Preparation of NLS conjugated protein and GST-NES-GFP 
protein 
As a substrate for nuclear import assays, fluorescein isothiocyanate 
(FITC)-labeled bovine serum albumin (BSA) or allophycocyanin 
(APC) (Calbiochem) was chemically conjugated to the synthetic pep- 
tide (CYGGPKKKRKVEDP) containing the nuclear localization sig- 
nal of SV40 T-antigen as described previously [22,30] (FITC-T-BSA, 
T-APC). The number of conjugated peptides was estimated to be 3-5 
per BSA molecule and lo-12 per APC molecule by SDS-PAGE. 
As a substrate for nuclear export assays, GST-NES-GFP (green 
fluorescent protein) fusion protein was used. A full-length cDNA of 
GFP (containing the S65T mutation) (Clontech) was inserted into the 
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SmaIIXhoI site of pGEX-5X-2 (Pharmacia) to generate pGST-GFP. 
The synthesized oligonucleotide, corresponding to the NES of PKI 
(heat-stable protein kinase inhibitor), LALKLAGLDI [24], was in- 
serted into the BumHIISmaI site of pGST-GFP. The GST-NES- 
GFP fusion protein was expressed in E. coli strain JMl09 and purified 
to homogeneity using glutathione Sepharose (Pharmacia). 
2.4. Preparation of recombinant proteins for the cell-free import assay 
Recombinant PTAC58 [12], PTAC97 [16] and RanlTC4 [31] pro- 
teins were prepared from E. co/i as previously described. 
2.5. Microinjection 
Cells were seeded on indexed glass coverslips. Proteins were micro- 
injected through a glass capillary into the cytoplasm or nucleus of 
cells, along with RITC- or FITC-conjugated BSA to monitor the 
actual site of injection. Injected cells were incubated for the indicated 
time at 37°C before fixation. Localization of injected RITC- or FITC- 
conjugated protein or GFP fusion protein was examined directly after 
fixation. In order to determine the nucleadcytoplasmic ratio of the 
amount of cytoplasmically injected FITC-plO/NTF2, FITC-plO/ 
NTFZ-injected cells were analyzed on a confocal LSM410 Laser 
Scan Microscope system (Carl Zeiss, Inc.). RNA synthesis was visua- 
lized as described below. 
2.6. Indirect immuno/luorescence 
The BrUTP-injected cells were fixed with 3.7% formaldehyde in 
PBS for 20 min. oermeabilized with 0.5% Triton X-100 in PBS for 
5 min, and rinsecl’in 3% skim milk in PBS. The cells were incubated 
with mouse anti-BrdU mAbs and then with FITC-conjugated anti- 
mouse IgG (Cappel Co.) After extensive washing, the cells were then 
examined with an Axiophot microscope (Carl Zeiss, Inc.). 
2.7. Cell-free import assay 
Digitonin-permeabilized MDBK cells were prepared using metho- 
dology reported by Adam et al. [32]. Testing solutions contained 100 
pg/ml T-APC and transport buffer (20 mM HEPES, pH 7.3, 110 mM 
potassium acetate, 2 mM magnesium acetate, 5 mM sodium acetate, 
0.5 mM ethylene glycol bis-P-aminoethylether)-N,N,N’,N’-tetraacetic 
acid (EGTA), 2 mM DTT and 1 &ml each of aprotinin, leupeptin 
and pepstatin). For the nuclear-binding assay, incubation was per- 
formed on ice for 30 min in the presence of 40 &ml PTAC58 and 
40 @ml PTAC97, with or without 100 pg/ml of plO/NTF2. For the 
nuclear import assay, the incubation was performed at 30°C for 20 
min in the presence of 40 @ml PTAC58, 40 pg/ml PTAC97, 100 pg/ 
ml Ran/TC4, 10 or 100 pg/ml plO/NTFZ, 1 mM ATP, 5 mM creatine 
phosphate and 20 U/ml creatine phosphokinase. 
3. Results and discussion 
Human plO/NTF2 was expressed as recombinant protein in 
E. coli. The purified recombinant protein yielded a single band 
having the expected electrophoretic mobility by SDS-PAGE 
analysis (Fig. 1A). This recombinant plO/NTF2 protein was 
confirmed to support the nuclear import of NLS-containing 
substrate (T-APC) in an in vitro assay with digitonin-permea- 
bilized cells when added at a concentration of 5-20 &ml in 
the presence of recombinant Ran, the 58 kDa and 97 kDa 
components of PTAC (Fig. 5A) as described previously [18]. 
To elucidate the functional roles of plO/NTFZ in nuclear 
protein import in living cells, various concentrations of the 
recombinant plO/NTF2 were injected, along with the trans- 
port substrate (FITC-T-BSA), into the cytoplasm of cultured 
mammalian cells. After incubation at 37°C for 30 min, the 
cells were fixed and the localization of injected FITC-T-BSA 
was examined by fluorescence microscopy. As shown in Fig. 
2A, plO/NTF2 at a concentration of 0.2 mg/ml had no effect 
on nuclear protein import. In contrast, injection of more than 
1 mg/ml of plOMTF2 inhibited the nuclear import of FITC- 
T-BSA in a dose-dependent manner. Similar results were ob- 
tained by substituting nucleoplasmin (Xenopus karyophilic 
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Fig. I. A: Purified human plO/NTFZ. plO/NTF2 was purified from 
E. coli as described in Section 2. The purified plO/NTF2 is >90% 
pure as evidenced by SDS-PAGE. Molecular mass standards are in- 
dicated on the left of the panel. B: Subcellular location of injected 
plO/NTF2 cross-linked with FITC. FITC-plO/NTF2 was injected 
into the cytoplasm of HEL cells. The cells were then incubated at 
37°C for 20 min before fixation. This FITC-plO/NTF2 supports nu- 
clear protein import in the in vitro import assay (data not shown). 
protein) for FITC-T-BSA as a transport substrate (data not 
shown). 
In these experiments, as shown in Fig. lB, injected plO/ 
NTF2 was found to localize in the cytoplasm, nucleus and 
on the nuclear rim. Ran has been found to be involved, not 
only in nuclear protein import, but also in the nuclear export 
of NLS-containing protein [33] and mRNA [34,35]. In order 
to determine whether plO/NTF2 has any effect on the nuclear 
export of proteins, we injected GST-NES-GFP with and with- 
out recombinant plO/NTF2 into the nucleus of cultured HEL 
cells. After incubation at 37°C for 30 min, the localization of 
injected GST-NES-GFP was examined. As shown in Fig. 2B, 
nuclear injection of plO/NTFZ at a concentration of 0.2 mg/ 
ml had no effect on the nuclear protein export. In contrast, as 
in the case of the nuclear protein import, nuclear export of 
GST-NES-GFP was strongly inhibited by the injection ‘of 
more than 1 mg/ml of plO/NTF2. This suggests that the nu- 
clear import factor, plO/NTFZ, may well participate in the 
nuclear export of NES-containing proteins as well. Similar 
results were also obtained using HeLa, BHK, and MDBK 
cells (data not shown). 
It is well known that small non-nuclear molecules rapidly 
T Tachibana et al.IFEBS Letters 397 (1996) 177-182 179 
B 
GST-NES-GFP FITC-T-BSA 
plO/NTF2 
0.2 mg/ml 
plO/NTF2 
lmg/ml 
plO/NTF2 
Smg/ml 
Fig. 2. Effects of injected plO/NTF2 on nuclear protein import and export. FITC-T-BSA (1 mg/ml, A) or GST-NES-GFP (1 mg/ml, B) was in- 
jected with 0.2 mg/ml, 1 mg/ml, 5 mg/ml or without (-) recombinant plO/NTFZ protein into the cytoplasm (A) or nucleus (B) of HEL cells. 
These cells were then incubated at 37°C for 30 min before fixation. 
diffuse into the nucleus [36]. In another series of experiments, 
we attempted to determine if the injected recombinant ~101 
NTF2 specifically inhibits signal-mediated protein transport. 
RITC-myoglobin was injected with and without recombinant 
plO/NTF2 into the cytoplasm or the nucleus of HEL cells. 
After incubation at 37°C for 30 min, the localization of in- 
jetted RITC-myoglobin was examined (Fig. 3). The injected 
plO/NTF2 did not inhibit the diffusive import and export of 
myoglobin, a small non-nuclear protein. These results indicate 
that the nuclear pores were not physically obstructed and the 
inhibitory effect of injected plO/NTF2 is specific to signal- 
mediated nuclear import and export of proteins. 
To determine if RNA was synthesized in the cells after 
injection of plO/NTF2, BrUTP was injected with plO/NTF2 
into the nucleus of HEL cells. As shown in Fig. 4, plO/NTF2 
did not block RNA synthesis. After injection of plO/NTFZ, 
therefore, the cells were viable and the inhibition of nuclear 
import and export of proteins was not caused by cell death. 
The mechanism by which injected plO/NTF2 inhibits nucle- 
ar import and export of proteins in living cells remains an 
open question. As shown in Fig. lB, the injected FITC-plO/ 
NTF2, which had the same inhibitory activity on nuclear im- 
port and export of proteins as the non-labeled one, was lo- 
cated in the cytoplasm (3040%) and nucleus (60-70’55). More- 
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Fig. 3. Effects of injected plOMTF2 on the passive diffusion of small molecules to/from the nucleus. RITC-myoglobin (1 mg/ml) was injected 
with (lower) and without (upper) recombinant plO/NTFZ protein into cytoplasm (A) or nucleus (B) of HEL cells. These cells were then incu- 
bated at 37% for 30 min bef&e’fixation. 
over, nuclear rim accumulation was often observed. Similar 
results were obtained when the FITC-plO/NTF2 was injected 
control 
plO/NTF2 
BrUTP 
Fig. 4. Effects of injected plO/NTF2 on RNA synthesis. plOMTF2 
(5 mg/ml, lower) or BSA (5 mg/ml, upper) was injected with BrUTP 
(50 mM) into the nucleus of HEL cells. The cells were then incu- 
bated at 37°C for 30 min before fixation. RNA synthesis was de- 
tected by indirect immunofluorescence staining with mouse anti- 
BrdU mAbs, and then with FITC-conjugated antibodies to mouse 
IgG. 
into the nucleus (data not shown). It has already been shown 
that plO/NTF2 interacts with nuclear pore protein ~62. It is 
likely that excess plO/NTF2 may interact immoderately with 
nuclear pore proteins which are required for nuclear transport 
such as p62 and thus inhibit nuclear protein import and ex- 
port. While this work was in progress, Nehrbass and Blobel 
reported that plO/NTF2 binds directly to several peptide re- 
peat-containing nucleoporins, and supports GDP-GTP ex- 
change for Ran on nucleoporins and the dissociation of the 
karyopherin-a (58 kDa component of PTAC) from the kar- 
yopherin afl heterodimer, after targeting to nucleoporins [37]. 
Exogenously injected excess plO/NTF2 may disrupt this series 
of reactions. 
We also found that the concentration of plO/NTF2 utilized 
in the in vitro assay using recombinant factors (plO/NTF2, 
Ran, PTAC58 and PTAC97) required for nuclear import is 
critical. That is, when Ran (100 @ml), PTAC58 (40 pg/ml) 
and PTAC97 (40 @ml) were used, 5-20 @ml of plO/NTF2 
permitted the efficient nuclear import of the substrate, but a 
larger amount ( N 100 kg/ml) of plO/NTF2 inhibited import 
(Fig. 5A). In contrast, when 100 pg/ml of plO/NTF2 was 
added to the in vitro assay on ice in the presence of 
PTAC58 (40 Fg/ml) and PTAC97 (40 @ml), the binding of 
T-APC to the nuclear rim was not inhibited (Fig. 5B). These 
results suggest that the in vivo inhibition of nuclear transport 
by exogenously injected plO/NTFZ may be due to an imbal- 
ance in the concentration of intracellular plO/NTF2 relative to 
other import factors and that the inhibition by plO/NTF2 
may occur at the translocation step of nuclear import. From 
these findings, it is plausible to assume that the nuclear trans- 
port efficiency between the cytoplasm and the nucleus may be 
regulated by controlling the expression of plO/NTFZ in cells. 
In contrast, the expression of plO/NTF2 in cells may be 
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Fig. 5. Effects of plO/NTF2 on nuclear protein import in the in vitro assay. MDBK cells permeabilized with digitonin were incubated at 30°C 
for 20 min with transport buffer in the presence of 100 ug/ml T-APC, 40 ug/ml PTAC58, 40 ug/ml PTAC97, 100 @ml RaniTC4, 10 or 100 
@ml plO/NTF2, 1 mM ATP and its regeneration system (A) or on ice for 30 min in the presence of 100 ug/ml T-APC, 40 ug/ml PTAC58 
and 40 ug/ml PTAC97, with or without 100 pg/ml plO/NTF2 (B). 
strictly controlled so as to support constant and efficient nu- 
clear transport. 
Clearly, additional in vivo and in vitro experiments are 
needed in order to understand the exact roles of plO/NTF2 
on the regulation of nuclear protein transport. The data col- 
lected here, however, suggest that plO/NTF2 may participate, 
not only in nuclear import, but also in nuclear export, and 
that nuclear import and export may be actually regulated by 
changes in the levels of plO/NTF2 in living cells. 
Moreover, the present study showed that injected ~101 
NTF2 inhibits signal-mediated nuclear import and export 
but not passive diffusion in living cells, and that the ~101 
NTF2 protein is easy to handle because it is small and soluble. 
As a result, recombinant plO/NTF2 protein will be useful as a 
tool to examine physiological phenomena which involve active 
protein transport between the nucleus and cytoplasm in living 
cells. 
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